Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Receptagen Ltd. -- Ignore unavailable to you. Want to Upgrade?

To: Russell J. Gilbert who wrote (114)	7/10/1998 7:07:00 PM
From: Russell J. Gilbert	Read Replies (1) \| Respond to of 203

Receptagen closed today at .05 U.S./share. I would appreciate if there are some RCG shareholders that access this thread to try and contact management at Global Research Network in order to try and gain an understanding where the new company is planning to go. I think most RCG shareholder have a good understanding of RCG's core compentancies but it would be useful to try and gain an insight on what GRN is planning to do after the merger is completed.